Mr. Xu brings over two decades of investment experience to Redhill Capital. He has held positions as a partner at Detong Capital, deputy general manager of Fosun Pharmaceutical Investment HQ, and served in institutions like Chinese Academy of Sciences Holdings Co., Ltd. and Tsinghua Xingye Investment Management Co., Ltd. During his career, he led investments in industry-leading projects including Huakan Biology, Mengke Pharmaceutical (688373), Shulan Medical, Donglei Brain Science, Liangyihui, Tiankeya Biology, Houkai Medical, Sinopharm Stomatology, and Micro Medicine Group.  Additionally, he has served as a director for Chengdu Information of Chinese Academy of Sciences, Beilai Biology, and other companies.
 
Mr. Xu is a Lecturer in Innovation and Entrepreneurship at Tsinghua University, a mentor for the Tsinghua Wudaokou Global Entrepreneurship Project, a distinguished researcher at Peking University Medical Information Consulting Center and serves on the Editorial Board Member of Progress in Pharmacy. He is also a mentor for the IBM Global Entrepreneur Training Camp and Zhongguancun Angel Growth Camp. In the past, he served as the co-chairman of the China Venture Capital Commission, and as an executive director of the Beijing Fund Industry Association.
 
Mr. Xu holds an EMBA from the Wudaokou School of Finance, a Master of Science from Tsinghua University, and has attended graduate school at the Chinese Academy of Sciences.
 
Honors and Achievements:

• 2020-2021 Arterial Network Annual Health Care Investor
• 2019 Zhongguancun High End Leading Talents (Beijing)
• 2018 Zhongguancun Venture Capital Star
• 2015 Fosun Pharmaceutical Annual Manager Award